Suppr超能文献

3%与7.5%高渗盐水用于创伤性低血容量休克复苏的比较

Comparison of 3% and 7.5% Hypertonic Saline in Resuscitation After Traumatic Hypovolemic Shock.

作者信息

Han Juan, Ren Hui-Qin, Zhao Qing-Bo, Wu You-Liang, Qiao Zhuo-Yi

机构信息

Emergency Department, PLA 324 Hospital, Chongqing, China.

出版信息

Shock. 2015 Mar;43(3):244-9. doi: 10.1097/SHK.0000000000000303.

Abstract

Hypertonic saline solutions (HSSs) (7.5%) are useful in the resuscitation of patients with hypovolemic shock because they provide immediate intravascular volume expansion via the delivery of a small volume of fluid, improving cardiac function. However, the effects of using 3% HSS in hypovolemic shock resuscitation are not well known. This study was designed to compare the effects of and complications associated with 3% HSS, 7.5% HSS, and standard fluid in resuscitation. In total, 294 severe trauma patients were enrolled from December 2008 to February 2012 and subjected to a double-blind randomized clinical trial. Individual patients were treated with 3% HSS (250 mL), 7.5% HSS (250 mL), or lactated Ringer's solution (LRS) (250 mL). Mean arterial pressure, blood pressure, and heart rate were monitored and recorded before fluid infusion and at 10, 30, 45, and 60 min after infusion, and the incidence of complications and survival rate were analyzed. The results indicate that 3% and 7.5% HSSs rapidly restored mean arterial pressure and led to the requirement of an approximately 50% lower total fluid volume compared with the LRS group (P < 0.001). However, a single bolus of 7.5% HSS resulted in an increase in heart rate (mean of 127 beats/min) at 10 min after the start of resuscitation. Higher rates of arrhythmia and hypernatremia were noted in the 7.5% HSS group, whereas higher risks of renal failure (P< 0.001), coagulopathy (P < 0.001), and pulmonary edema (P < 0.001) were observed in the LRS group. Neither severe electrolyte disturbance nor anaphylaxis was observed in the HSS groups. It is notable that 3% HSS had similar effects on resuscitation because both the 7.5% HSS and LRS groups but resulted in a lower occurrence of complications. This study demonstrates the efficacy and safety of 3% HSS in the resuscitation of patients with hypovolemic shock.

摘要

高渗盐溶液(HSSs)(7.5%)在低血容量性休克患者的复苏中很有用,因为它们通过输注少量液体即可立即实现血管内容量扩张,从而改善心脏功能。然而,3% HSS在低血容量性休克复苏中的效果尚不清楚。本研究旨在比较3% HSS、7.5% HSS和标准液体在复苏中的效果及相关并发症。2008年12月至2012年2月,共纳入294例严重创伤患者,进行双盲随机临床试验。个体患者分别接受3% HSS(250 mL)、7.5% HSS(250 mL)或乳酸林格氏液(LRS)(250 mL)治疗。在输液前以及输液后10、30、45和60分钟监测并记录平均动脉压、血压和心率,并分析并发症发生率和生存率。结果表明,与LRS组相比,3%和7.5% HSS能迅速恢复平均动脉压,且所需的总液体量降低约50%(P < 0.001)。然而,单次推注7.5% HSS在复苏开始后10分钟时导致心率增加(平均127次/分钟)。7.5% HSS组的心律失常和高钠血症发生率较高,而LRS组观察到更高的肾衰竭风险(P< 0.001)、凝血病风险(P < 0.001)和肺水肿风险(P < 0.001)。HSS组均未观察到严重电解质紊乱或过敏反应。值得注意的是,3% HSS在复苏方面具有与7.5% HSS相似的效果,但并发症发生率较低。本研究证明了3% HSS在低血容量性休克患者复苏中的有效性和安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验